ライフサイエンスコーパス: stress echocardiography

1 ctrocardiography, nuclear stress testing, or stress echocardiography).

2 sound contrast agents in patients undergoing stress echocardiography.

3 exercise capacity, and inducible ischemia on stress echocardiography.

4 d contrast agents; 18,749 of these underwent stress echocardiography.

5 ventricular flow reserve (FR) on dobutamine stress echocardiography.

6 ies, conducted an appropriateness review for stress echocardiography.

7 ely used in the prognostic interpretation of stress echocardiography.

8 s underwent exercise treadmill or dobutamine stress echocardiography.

9 improve the accuracy and reproducibility of stress echocardiography.

10 ication and prognosis in patients undergoing stress echocardiography.

11 ot have inducible ischemia, as determined by stress echocardiography.

12 ocardial perfusion defects during dobutamine stress echocardiography.

13 promising important addition to conventional stress echocardiography.

14 in 114 of the 117 patients during dobutamine stress echocardiography.

15 rophy on the accuracy of dobutamine-atropine stress echocardiography.

16 ial ischemia in patients not well suited for stress echocardiography.

17 le, well-tolerated alternative to dobutamine stress echocardiography.

18 entional visual interpretation of dobutamine stress echocardiography.

19 pic incompetence among patients referred for stress echocardiography.

20 tress testing and transesophageal dobutamine stress echocardiography.

21 154 patients without ischemia on dobutamine stress echocardiography.

22 a large patient group undergoing dobutamine stress echocardiography.

23 ary artery disease or ischemia at dobutamine stress echocardiography.

24 standardized assessment including dobutamine stress echocardiography.

25 ting, symptom questionnaires, and dobutamine stress echocardiography.

26 ists on stress FR during low-dose dobutamine stress echocardiography.

27 ork index variables during normal dobutamine stress echocardiography.

28 erformance and was evaluated during exercise stress echocardiography.

29 s incremental prognostic utility of exercise stress echocardiography.

30 aging, stress single-photon emission CT, and stress echocardiography.

31 ed performance characteristics compared with stress echocardiography.

32 metric protocol in 119 patients referred for stress echocardiography.

33 were discharged and referred for outpatient stress echocardiography.

34 gradient increased or did not change during stress echocardiography.

35 5%) were prospectively submitted to exercise stress echocardiography.

36 ignificantly shorter than that of dobutamine stress echocardiography (15.1+/-3.9 min) (p = 0.0001).

37 (112 of 122 [92%]) than exercise testing and stress echocardiography (21 of 122 [17%]) or echocardiog

38 r exercise treadmill testing (2.3% to 1.7%), stress echocardiography (3.6% to 2.6%), multigated acqui

39 s (59 +/- 13 years old; 51% male) undergoing stress echocardiography (34% with treadmill exercise and

40 Fifty-four patients who underwent stress echocardiography (36 exercise, 18 dobutamine) and

41 rfusion (1,994 patients) and 5 on dobutamine stress echocardiography (446 patients).

42 PS, there was lower associated spending with stress echocardiography (-$4981 [-$4991 to -$4969]; P <

43 .55] vs. 55% [95% CI: 0.44 to 0.65]) but not stress echocardiography (53% [95% CI: 0.45 to 0.61] vs.

44 seline evaluation included echocardiography, stress echocardiography, 6-minute walk test, biomarkers,

45 icular ejection fraction undergoing exercise stress echocardiography, a lower % of age-sex-predicted

46 The greater the downstream stress echocardiography abnormality caused by a stenosis

47 ction underwent serial quantitative exercise stress echocardiography after 3 weeks on each treatment

48 Stress echocardiography alone is not reliable in screeni

49 artery disease (CAD) as measured by exercise stress echocardiography among outpatients with stable CA

50 Cardiologist-performed stress echocardiography and cardiac catheterization and

51 panel of noninvasive assessments, including stress echocardiography and cardiopulmonary exercise tes

52 secutive patients undergoing both dobutamine stress echocardiography and coronary angiography, electr

53 nts underwent multistage dobutamine-atropine stress echocardiography and diagnostic angiography.

54 Dobutamine-atropine stress echocardiography and DMIBI were comparable tests

55 Dobutamine-atropine stress echocardiography and DMIBI were moderately concor

56 Dobutamine-atropine stress echocardiography and DMIBI were similarly sensiti

57 rformed during low- and high-dose dobutamine stress echocardiography and have been applied to exercis

58 relation between myocardial ischemia during stress echocardiography and major events in patients wit

59 nvasive functional screening methods such as stress echocardiography and myocardial perfusion scintig

60 authors discuss the relative merits of both stress echocardiography and myocardial single photon emi

61 Patients underwent stress echocardiography and radionuclide perfusion imagi

62 (including exercise electrocardiography and stress echocardiography and single-photon emission compu

63 Dobutamine-atropine stress echocardiography and stress-rest DMIBI were perfo

64 perfusion abnormalities in real-time during stress echocardiography and will further add to the qual

65 , discusses new data regarding the safety of stress echocardiography, and highlights emerging roles f

66 h RTMCE improves the detection of CAD during stress echocardiography, and identifies those more likel

67 ing the critically ill), patients undergoing stress echocardiography, and patients with pulmonary hyp

68 photon emission computed tomography (SPECT), stress echocardiography, and positron emission tomograph

69 ocardiography, to contrast echocardiography, stress echocardiography, and TEE, among others.

70 Transthoracic echocardiography, stress echocardiography, and/or myocardial perfusion ima

71 g its diagnostic accuracy.3) Pharmacological stress echocardiography appears to provide superior spec

72 Comparable data for stress echocardiography are emerging.

73 n risk stratification of patients undergoing stress echocardiography are limited.

74 adionuclide myocardial perfusion imaging and stress echocardiography are noninvasive imaging techniqu

75 a in diabetic patients to define the role of stress echocardiography as a prognostic tool.

76 sought to document the safety of dobutamine stress echocardiography as it has evolved at a single ce

77 elines identify the low-risk response during stress echocardiography as the absence of regional wall

78 in a double-blind fashion during dobutamine stress echocardiography, at separate visits and in a ran

79 ess SPECT MPI and 298 patients who underwent stress echocardiography before publication of these crit

80 d eighty-three patients underwent dobutamine stress echocardiography before randomization.

81 al radionucleotide stress test or dobutamine stress echocardiography before transplant.

82 s with class III/IV CHF underwent dobutamine stress echocardiography before treatment with bucindolol

83 Transesophageal atrial pacing stress echocardiography began at a heart rate of 10 beat

84 rea <=2 cm) who underwent rest and treadmill stress echocardiography between 1/2003 and 12/2013.

85 onary artery disease) who underwent exercise stress echocardiography between 2001 and 2012.

86 performed in 117 patients during dobutamine stress echocardiography by using an intravenous bolus of

87 ment of myocardial perfusion during exercise stress echocardiography can be achieved with imaging at

88 ntage of a prolonged dobutamine stage during stress echocardiography can be effectively combined with

89 We conclude that dobutamine stress echocardiography can be used to predict which pat

90 Rest and exercise-stress echocardiography, CMR and right heart catheterisa

91 urrence of stress imaging (stress nuclear or stress echocardiography), coronary angiography, or coron

92 een appropriateness and publication year for stress echocardiography, CTA, or single-photon emission

93 Dobutamine-atropine stress echocardiography (DASE) (baseline, low dose [5 an

94 Dobutamine-atropine stress echocardiography (DASE) accurately detects scar,

95 We sought to compare dobutamine-atropine stress echocardiography (DASE) and dipyridamole Techneti

96 rdiographic Cardiac Risk Evaluation Applying Stress Echocardiography), DECREASE-IV, and POISE-1 (Peri

97 es (exercise ECG, stress nuclear methods, or stress echocardiography) did not improve clinical outcom

98 he diagnostic and prognostic capabilities of stress echocardiography, discusses new data regarding th

99 Stress echocardiography done using various methods has b

100 ablished diagnostic modalities of dobutamine stress echocardiography (DSE) and rest-redistribution th

101 pre-randomization treadmill CPET, dobutamine stress echocardiography (DSE) and symptom assessment.

102 od pressure (BP) responses during dobutamine stress echocardiography (DSE) are associated with abnorm

103 tion techniques were studied with dobutamine stress echocardiography (DSE) before TMLR.

104 valuated the incremental value of dobutamine stress echocardiography (DSE) for assessment of cardiac

105 safety and diagnostic accuracy of dobutamine stress echocardiography (DSE) for evaluating posttranspl

106 ject was to assess the utility of dobutamine stress echocardiography (DSE) for evaluation of women wi

107 determine the prognostic value of dobutamine stress echocardiography (DSE) for predicting long-term o

108 (WMA) during submaximal and peak dobutamine stress echocardiography (DSE) for the diagnosis of coron

109 d subsequent deterioration during dobutamine stress echocardiography (DSE) has been increasingly used

110 MCR during dobutamine stress echocardiography (DSE) identifies viable myocardi

111 prognostic significance of serial dobutamine stress echocardiography (DSE) in new heart transplant re

112 ctive value (NPV) of preoperative dobutamine stress echocardiography (DSE) in patients who fail to ac

113 ought to determine the utility of dobutamine stress echocardiography (DSE) in predicting cardiac even

114 To assess the role of dobutamine stress echocardiography (DSE) in these patients, DSE was

115 that the abnormalities induced by dobutamine stress echocardiography (DSE) may be of prognostic value

116 ial perfusion scintigraphy (MPS), dobutamine stress echocardiography (DSE) or coronary angiography, p

117 (TAPSE) protocol with a standard dobutamine stress echocardiography (DSE) protocol.

118 Because dobutamine stress echocardiography (DSE) provides assessment of lef

119 nd-stage liver disease undergoing dobutamine stress echocardiography (DSE) were evaluated at an LT ce

120 ron emission tomography (PET) and dobutamine stress echocardiography (DSE) were performed to quantita

121 tients who underwent conventional dobutamine stress echocardiography (DSE) without contrast.

122 in myocardial contraction during dobutamine stress echocardiography (DSE), particularly a biphasic r

123 to provide superior specificity to exercise stress echocardiography due to difficulties in test exec

124 286 patients underwent dobutamine stress echocardiography during the study period.

125 ve) exercise electrocardiography, but normal stress echocardiography (+ECG/-Echo), have an increased

126 C) published for radionuclide imaging (RNI), stress echocardiography (Echo), calcium scoring, coronar

127 Canine studies have shown that dobutamine stress echocardiography end points will occur at a lower

128 t rest, and more frequently, during exercise stress echocardiography (ESE).

129 For U.K. women, the optimal strategy was stress echocardiography followed by catheter-based coron

130 y was assessed by a core lab with dobutamine stress echocardiography, followed by a multidetector com

131 agnostic tests.2) Strong comparative data on stress echocardiography for detecting coronary artery di

132 RTCE) improves the sensitivity of dobutamine stress echocardiography for detecting coronary artery di

133 etics and 11 305 nondiabetics) who underwent stress echocardiography for evaluation of known (n=5671)

134 Of 6174 consecutive adults undergoing stress echocardiography for evaluation of known or suspe

135 underwent outpatient exercise or dobutamine stress echocardiography for known or suspected coronary

136 Use of stress echocardiography for risk assessment in patients

137 he review assessed the risks and benefits of stress echocardiography for several indications or clini

138 ificity, and accuracy of dobutamine-atropine stress echocardiography for the detection of coronary ar

139 ockade affects the sensitivity of dobutamine stress echocardiography for the diagnosis of coronary ar

140 ography is an alternative method to exercise stress echocardiography for the evaluation of ischemia.

141 sed using quantitative coronary angiography, stress echocardiography, fractional flow reserve, and in

142 phically guided revascularization (n=154) or stress echocardiography-guided revascularization (n=152)

143 d point occurred in 21 (14%) patients of the stress echocardiography-guided revascularization group a

144 ographically guided revascularization versus stress echocardiography-guided revascularization in pati

145 ocardial infarction and multivessel disease, stress echocardiography-guided revascularization may not

146 A microparticle rise during stress echocardiography had occurred only in those with

147 Stress cardiac MR imaging and stress echocardiography had similar specificity, accurac

148 Transesophageal atrial pacing stress echocardiography has been proposed as an efficien

149 Stress echocardiography has been shown to identify diffe

150 Dobutamine stress echocardiography has been the cornerstone of card

151 Increasingly, dobutamine stress echocardiography has been used for detection of c

152 Although dobutamine stress echocardiography has improved sensitivity and spe

153 Although appropriateness criteria for stress echocardiography have been developed to deliver h

154 mic myocardium, nuclear medicine studies and stress echocardiography have failed to adequately select

155 ms) with significant MS undergoing treadmill stress echocardiography, higher mortality was associated

156 pEF develop B-lines upon submaximal exercise stress echocardiography; however, whether exercise-induc

157 x (HR, 1.65; 95% CI, 1.41-1.93), ischemia at stress echocardiography (HR, 1.54; 95% CI, 1.32-1.80), a

158 R, 2.43; 95% CI, 1.83-3.22), and ischemia at stress echocardiography (HR, 1.71; 95% CI, 1.34-2.18).

159 Dobutamine stress echocardiography identified 60% of patients as lo

160 phology and function as assessed by rest and stress echocardiography in 156 asymptomatic National Foo

161 rtake exercise treadmill testing in 2024 and stress echocardiography in 2025.

162 results strongly support the use of exercise stress echocardiography in asymptomatic aortic stenosis.

163 tudies emphasized the usefulness of exercise stress echocardiography in asymptomatic patients with ao

164 The sensitivity of stress echocardiography in detecting significant CAD was

165 dly affects the negative predictive value of stress echocardiography in nondiabetic patients, whereas

166 overall diagnostic sensitivity of dobutamine stress echocardiography in our study cohort.

167 e performing exercise treadmill testing with stress echocardiography in outpatients with stable coron

168 as a potential substitute for pharmacologic stress echocardiography in patients admitted to the hosp

169 assessment of cardiac power during exercise stress echocardiography in patients with normal EF provi

170 igations evaluating the prognostic effect of stress echocardiography in patients with stable coronary

171 ed supporting the prognostic capabilities of stress echocardiography in patients with various levels

172 To determine the value of dobutamine stress echocardiography in predicting cardiac events, in

173 e long-term prognostic utility of dobutamine stress echocardiography in predicting fatal and nonfatal

174 wall motion (WM) analysis during dobutamine stress echocardiography in predicting the outcome of pat

175 underwent both stress cardiac MR imaging and stress echocardiography in random order within 12 hours

176 s review discusses some of the advantages of stress echocardiography in relation to recent publicatio

177 diography, and highlights emerging roles for stress echocardiography in the areas of left ventricular

178 ral studies are available on the accuracy of stress echocardiography in the detection of coronary art

179 dly and shows good agreement with dobutamine stress echocardiography in the induction of myocardial i

180 atures, including ischemia during dobutamine stress echocardiography, in predicting postoperative car

181 r exercise, except among patients undergoing stress echocardiography, in whom the cutoff was < or =18

182 Use of stress echocardiography increased by 27.8% from 2005 (70

183 Dobutamine stress echocardiography increased mean gradient from bas

184 Transesophageal atrial pacing stress echocardiography is a feasible, well-tolerated al

185 Ischemia at stress echocardiography is a strong and independent pred

186 Dobutamine stress echocardiography is a useful tool for assessing l

187 Dobutamine stress echocardiography is a validated tool for the non-

188 Dobutamine-atropine stress echocardiography is an accurate test in most pati

189 Dobutamine stress echocardiography is an alternative method to exer

190 Stress echocardiography is an established technique for

191 Ischemia during stress echocardiography is an independent predictor of d

192 Stress echocardiography is commonly employed for the cli

193 Real-time three-dimensional dobutamine stress echocardiography is feasible and sensitive in the

194 Stress echocardiography is increasingly used for the ass

195 ite these known pharmacodynamics, dobutamine stress echocardiography is routinely performed by advanc

196 Dobutamine stress echocardiography is widely accepted as a noninvas

197 Dobutamine stress echocardiography is widely used to test for ische

198 In patients referred for stress echocardiography, LA size provides independent an

199 The versatility and advantage of stress echocardiography lie in the fact that it provides

200 Dobutamine-atropine stress echocardiography may be advantageous in patients

201 urement of GLS at rest and during dobutamine stress echocardiography may be helpful to enhance risk s

202 Studies are now suggesting that stress echocardiography may play novel roles in the eval

203 Stress GLS measured during dobutamine stress echocardiography may provide incremental prognost

204 Data suggest that dobutamine stress echocardiography may underestimate viability in c

205 Dobutamine stress echocardiography, myocardial perfusion scintigrap

206 The effect of the location of WMAs during stress echocardiography on prognostic outcome is unknown

207 ain (GLS) measured at rest and at dobutamine stress echocardiography on the outcome of patients with

208 aphy, and ventricular wall motion imaging by stress echocardiography or cardiac magnetic resonance.

209 cise electrocardiography, nuclear stress, or stress echocardiography) or anatomic testing.

210 cise electrocardiography, nuclear stress, or stress echocardiography) or coronary computed tomography

211 with resting or stress electrocardiography, stress echocardiography, or myocardial perfusion imaging

212 with resting or stress electrocardiography, stress echocardiography, or stress myocardial perfusion

213 d from 860 patients who underwent dobutamine stress echocardiography over a 2-year period.

214 t ischemic dilation of the left ventricle on stress echocardiography (P = 0.05), magnitude of ST-segm

215 The global and segmental stress echocardiography parameters of stunning were atte

216 d at enrollment in CIAO (P=0.46) or ISCHEMIA stress echocardiography participants (P=0.35).

217 rmation and guides treatment decisions, with stress echocardiography particularly valuable for detect

218 w studies continue to document the safety of stress echocardiography, particularly with regard to arr

219 c accuracy and feasibility of bedside pacing stress echocardiography (PASE) as a potential substitute

220 he degree of ischemia assessed by dobutamine stress echocardiography predicts the placebo-controlled

221 ractile reserve, as determined by dobutamine stress echocardiography, predicts improvement in LVEF.

222 asive imaging techniques, such as dobutamine stress echocardiography, radionuclide scintigraphy and c

223 There were no major exercise stress echocardiography-related complications.

224 Dobutamine stress echocardiography reliably detects multivessel ste

225 Stress echocardiography represents a dynamic, versatile,

226 Stress echocardiography represents a well validated tool

227 $501 to $514 for pharmacologic and exercise stress echocardiography, respectively; and $946 to $1132

228 Dobutamine stress echocardiography results in a decrease of all spe

229 To compare the capability by stress echocardiography results to predict overall morta

230 ntrolled effect in patients with the highest stress echocardiography score (P(interaction)=0.031).

231 were unable to detect an interaction between stress echocardiography score and any other patient-repo

232 ife score (P(interaction)=0.789), or between stress echocardiography score and physician-assessed Can

233 ectable interaction between prerandomization stress echocardiography score and the effect of PCI on a

234 The stress echocardiography score is broadly the number of s

235 studied the ability of the prerandomization stress echocardiography score to predict the placebo-con

236 diameter stenosis was 61% (Q1-Q3: 49%-74%), stress echocardiography score was 1.0 (Q1-Q3: 0.0-2.7),

237 At baseline, the median stress echocardiography score was 1.42 in the PCI group

238 At prerandomization, the stress echocardiography score was 1.56+/-1.77 in the PCI

239 Stress echocardiography scores were calculated for each

240 Higher stress echocardiography scores were strongly associated

241 expands the risk stratification potential of stress echocardiography (SE) based on stress-induced reg

242 The real-world clinical value of stress echocardiography (SE) in these patients is unknow

243 Stress echocardiography (SE) was recently upgraded to th

244 sk of cardiac events in patients with normal stress echocardiography (SE) who attained maximal age-pr

245 left atrial (LA) size in patients undergoing stress echocardiography (SE).

246 icular (RV) wall motion abnormalities during stress echocardiography (SE).

247 ve results.4) Current evidence suggests that stress echocardiography should be the first-line diagnos

248 re established techniques such as dobutamine stress echocardiography, single photon emission computed

249 for myocardial perfusion scintigraphy (MPS), stress echocardiography (STE), or coronary computed tomo

250 veral noninvasive imaging techniques such as stress echocardiography, stress nuclear studies, compute

251 or angiography alone, or treadmill exercise, stress echocardiography, stress thallium or predetermine

252 new two-stage transesophageal atrial pacing stress echocardiography (TAPSE) protocol with a standard

253 The adjusted OR of stress echocardiography testing among patients treated b

254 Nuclear stress testing and stress echocardiography testing following revascularizat

255 For stress echocardiography, the cumulative incidence of tes

256 With transesophageal atrial pacing stress echocardiography, the recovery period was shorter

257 osis used as controls) undergoing dobutamine stress echocardiography to assess FR and cardiac magneti

258 total, 314 individuals underwent dobutamine stress echocardiography to detect or exclude myocardial

259 eckle tracking at rest and during dobutamine stress echocardiography to document the extent of myocar

260 solated PEX referred to undergo chest CT and stress echocardiography to evaluate surgical candidacy a

261 The ability of prerandomization stress echocardiography to predict the placebo-controlle

262 he authors systematically employed exercise (stress) echocardiography to define those patients withou

263 an LVEF <or=55% that were poorly suited for stress echocardiography underwent DCMR in which left ven

264 Stress echocardiography uniquely identifies these high-r

265 ied 788 patients with RTCE during dobutamine stress echocardiography using intravenous commercially a

266 f change continues, are projected to surpass stress echocardiography volumes in 2024.

267 Dobutamine stress echocardiography was abnormal in 10 of these 25 w

268 GLS <|10|% measured during dobutamine stress echocardiography was also independently associate

269 In these strategies, stress echocardiography was consistently more effective

270 Transesophageal atrial pacing stress echocardiography was feasible in 100 of 104 patie

271 A standard protocol of dobutamine stress echocardiography was first performed.

272 Abnormal stress echocardiography was identified in 57 patients (3

273 Aspirin use among patients undergoing stress echocardiography was independently associated wit

274 standard 3-min dobutamine dose stage during stress echocardiography was modified by extending the pe

275 Dobutamine stress echocardiography was normal in 54 of the 67 women

276 Ischemia at stress echocardiography was observed in 768 (27%) diabet

277 Dobutamine stress echocardiography was performed in 1,171 patients

278 Dobutamine stress echocardiography was performed in 165 patients fo

279 Multistage dobutamine-atropine stress echocardiography was performed in 232 patients (a

280 Bedside transthoracic stress echocardiography was performed in 54 consecutive

281 Stress echocardiography was performed to estimate myocar

282 Dobutamine-atropine stress echocardiography was safely used to detect residu

283 the original stenosis zone during dobutamine stress echocardiography was significantly lower when two

284 Transesophageal atrial pacing stress echocardiography was successful in 35 of the 36 p

285 Dobutamine stress echocardiography was used in 30 patients (mean [+

286 Exercise stress echocardiography was used to identify inducible i

287 Stress FR during low-dose dobutamine stress echocardiography was useful for the detection of

288 Pacing stress echocardiography was well tolerated, and only 4%

289 D, stress testing (nuclear stress testing or stress echocardiography) was performed in 7.9% of new-on

290 stenosis (MS) undergoing rest and treadmill stress echocardiography, we assessed characteristics and

291 minations of patients with normal dobutamine stress echocardiography were collected and underwent off

292 he results of exercise treadmill testing and stress echocardiography were compared with those obtaine

293 bability referred for dobutamine or exercise stress echocardiography were prospectively randomized to

294 ent were given at rest and during dobutamine stress echocardiography when a single coronary artery st

295 n patients unable to exercise, pharmacologic stress echocardiography with dobutamine or vasodilators

296 Dobutamine stress echocardiography with semiquantitative segmental

297 ype 2 diabetes mellitus underwent dobutamine stress echocardiography with tissue Doppler imaging on 2

298 Dobutamine stress echocardiography with use of the wall-motion scor

299 This article reviews the recent advances in stress echocardiography, with particular attention to ar

300 Stress echocardiography yields prognostic information fo